Pura Vida Investments’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
Pura Vida Investments's XLRN Position: Q3 2020 in Review
Pura Vida Investments sold out of Acceleron Pharma (XLRN) in Q3 2020, closing a stake of 20,400 shares — an estimated $1.94M sold.
Pura Vida Investments first reported a position in XLRN in Q1 2020 and held it in 2 quarters. The position peaked at $6.89M in Q1 2020. 238 funds tracked by Wall St. Rank hold XLRN as of Q3 2020.
- Pura Vida Investments reported no remaining Acceleron Pharma position as of Q3 2020 after selling out during the quarter.
- Pura Vida Investments sold 20,400 Acceleron Pharma shares in Q3 2020, an estimated $1.94M.
- Pura Vida Investments first reported a position in Acceleron Pharma in Q1 2020 and held it in 2 quarters.
- Pura Vida Investments's Acceleron Pharma position peaked at $6.89M in Q1 2020.
- 238 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2020.
Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.